⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
globenewswire.com
RARE
Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
globenewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action - RGRD Law
globenewswire.com
RARE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
accessnewswire.com
RARE
Pomerantz LLP Issues Reminder to Shareholders in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit – RARE
accessnewswire.com
RARE
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
prnewswire.com
RARE
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
globenewswire.com
RARE
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
globenewswire.com
RARE
Pomerantz LLP Informs Shareholders of Class Action Filing Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Contact The Gross Law Firm by April 6, 2026 Deadline to Join Class Action Against Ultragenyx Pharmaceutical Inc.(RARE)
globenewswire.com
RARE